Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)

BACKGROUND: In patients with relapsing remitting multiple sclerosis (RRMS) the persistence of and adherence to disease modifying drug (DMD) treatment is inadequate. To take individualised measures there is a need to identify patients with a high risk of non-persistence or non-adherence. As patient-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongen, Peter Joseph, Lemmens, Wim A., Hoogervorst, Erwin L., Donders, Rogier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351176/
https://www.ncbi.nlm.nih.gov/pubmed/28292329
http://dx.doi.org/10.1186/s12955-017-0622-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351176/
https://www.ncbi.nlm.nih.gov/pubmed/28292329
http://dx.doi.org/10.1186/s12955-017-0622-z

Ejemplares similares